By Jovan Begovic, MD
Peer Reviewed
Last Friday, Aetna and Gilead Sciences, the well-known maker of Sovaldi, the “$1000-a-pill†treatment for Hepatitis C, reached a discount agreement that will allow Sovaldi to …
By Jovan Begovic, MD
Peer Reviewed
Last Friday, Aetna and Gilead Sciences, the well-known maker of Sovaldi, the “$1000-a-pill†treatment for Hepatitis C, reached a discount agreement that will allow Sovaldi to …
Please enjoy this post from the archives dated January 19, 2012
By Robert Gianotti, MD
Faculty Peer Reviewed
Case: Mr. T is a 32-year-old male being treated by the oncology service for …
By Jessica Yee, MD
Peer Reviewed
Welcome to the first PrimeCuts of 2015!
Welcome to the first PrimeCuts of 2015! The year started with a shout-out from 200 …
By Michael Lee, MD
Peer Reviewed
Clinical Case: Ms. A, an 84-year-old retired physician with a history of bronchiectasis of unclear etiology, is admitted with the chief complaint of chronic cough. Further …
Please enjoy this post from the archives, dated January 11, 2012
By Kristen Mattei
Faculty Peer Reviewed
I distinctly remember being 9 years old, sitting in my doctor’s office after a cold left me struggling for breath, doubled over and wheezing, when …
Sick and tired of all those top 10 lists? We beg your indulgence and hope you will tolerate just one more, the Clinical …
From all of us to all of you …Happy Holidays and Happy New Year! Clinical Correlations will be on a short hiatus. We will resume …
By: Kristina Cieslak
This Wednesday, President Obama announced plans to “end an outdated approach, that for decades, has failed to advance our interests,†ordering restoration of …